Skip to main content
Figure 3 | Head & Neck Oncology

Figure 3

From: The cost burden of oral, oral pharyngeal, and salivary gland cancers in three groups: commercial insurance, medicare, and medicaid

Figure 3

Health care costs of single versus multimodal cancer treatment. Notes: For sample with 1 year of follow-up. Medical and drug expenditures were adjusted to 2009 dollars using Medical Care CPI. The p-value is from a test of statistically significant differences between OC/OP/SG cancer patients who were treated with a single modality and those treated with multiple modalities.

Back to article page

Head & Neck Oncology

ISSN: 1758-3284